STAT+: French regulator fines Novo and Lilly over weight loss ad campaigns

France's medicines regulator has fined Novo Nordisk and Eli Lilly over their weight loss ad campaigns.
Source
Stat News
Opens original article in a new tab
AI Bias Analysis
4 models · Takes ~15 seconds

France's medicines regulator has fined Novo Nordisk and Eli Lilly over their weight loss ad campaigns.
Source
Stat News
Opens original article in a new tab

The 5th Circuit’s ruling on mifepristone “is bad for health care access, and it’s also bad for innovation,” writes Grace E. Colón.

(MedPage Today) -- Kids who had acute kidney injury (AKI) during a hospitalization often experienced lasting health consequences, a meta-analysis showed. Pooled cumulative incidences were 17% for chronic kidney disease (CKD), 6% for mortality...

(MedPage Today) -- When a 24-year-old woman took a dietary supplement called "raiz de tejocote," she encountered some dangerous and unpleasant side effects. On arrival to the emergency department, she was experiencing confusion, nausea, vomiting...

(MedPage Today) -- In "Beyond Diagnosis: Vaccines," Cleveland Clinic infectious disease specialist Donald Dumford III, MD, and host John Mangels continue their conversations on communicating effectively and empathetically with patients around vaccination...